Literature DB >> 2788321

Long term survival after treatment of disseminated T cell lymphoma presenting with tracheal obstruction in a patient with coeliac disease.

D J Seddon1, K F Chung, F J Paradinas, E S Newlands, P D Snashall.   

Abstract

A 46 year old man with coeliac disease and upper airway obstruction was thought to have undifferentiated carcinoma of the trachea. Subsequent immunohistological examination showed that the neoplasm was a T cell lymphoma. He had combination chemotherapy and is alive and well seven years after diagnosis.

Entities:  

Mesh:

Year:  1989        PMID: 2788321      PMCID: PMC1020816          DOI: 10.1136/thx.44.6.519

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

Review 1.  Modern management of non-Hodgkin's lymphoma.

Authors:  G M Mead; J M Whitehouse
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

2.  Primary B cell malignant lymphoma of the trachea.

Authors:  J Wiggins; E Sheffield; M Green
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

3.  Malignant histiocytosis of the intestine: a T-cell lymphoma.

Authors:  P G Isaacson; N T O'Connor; J Spencer; D H Bevan; C E Connolly; N Kirkham; D J Pollock; J S Wainscoat; H Stein; D Y Mason
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

4.  Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques.

Authors:  K C Gatter; C Alcock; A Heryet; D Y Mason
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

5.  The treatment of malignant histiocytosis.

Authors:  A Tseng; C N Coleman; R S Cox; T V Colby; R R Turner; S J Horning; S A Rosenberg
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

  5 in total
  1 in total

Review 1.  Primary tracheal lymphoma: case report and literature review.

Authors:  Akiyoshi Takami; Hirokazu Okumura; Yoshinobu Maeda; Yoshihisa Kumano; Hidesaku Asakura; Makoto Oda; Kenji Omura; Shinji Nakao
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.